Explore
Premium
Sign Up
Log In
CRT 2017 : ATHEROSCLEROSIS, PHYSIOLOGY AND IMAGING - Vulnerable Plaque Clinical Trials Update
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
ATHEROSCLEROSIS, PHYSIOLOGY AND IMAGING - Vulnerable Plaque Clinical Trials Update
Featuring
Steven Nissen
Takashi Akasaka
Ron Waksman
Gregg Stone
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Lessons From the GLACOV Study and the MILANO Pilot Study - Steven Nissen
Plaque Stabilization by Statin: From EASY-FIT to ESCORT Trial - Takashi Akasaka
Near-Infrared Spectroscopy: Lipid-Rich Plaque Study Update - Ron Waksman
Diagnosis NIRS and Treatment BVS of Vulnerable Plaque: PROSPECT II - Gregg Stone
Target Audience
Cardiologists
Interventional Cardiologists
Interventional Fellows
Interventional Radiologists
Vascular Surgeons
Emergency Physicians
Physicians with an interest in Cardiovascular Innovations
Learning Objectives
Related Moments
CRT 2016 Endovascular - Access for CLI
Conference
A session looking at Access for CLI from CRT 2016
Supported By
CRT 2017: ABC/FDA Luncheon Symposium: Inequalities In Interventional Cardiology - The Impact of Health Policy and Clinical Practice on Achieving Health Equity
Conference
Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
Journal
Article on Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
Loading Simple Education
